| Date Filed | Type | Description |
| 08/29/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/23/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Bodem Barbara W. (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 14,995 options to buy
@ $94.59, valued at
$1.4M
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| TOMBESI PAOLO (EVP & CFO) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 29,778 shares
@ $76, valued at
$2.3M
Disposed/sold 61,200 options to buy
@ $62.63, valued at
$3.8M
Disposed/sold 58,600 options to buy
@ $37.68, valued at
$2.2M
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Sabus Steve M (SVP & Chief Commercial Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 36,667 shares
@ $76, valued at
$2.8M
Disposed/sold 165,000 options to buy
@ $35.37, valued at
$5.8M
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/17/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/17/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/17/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/17/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/17/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/17/2022 |
8-K
| Quarterly results |
| 08/16/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/16/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/09/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/09/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/08/2022 |
8-K
| Quarterly results |
| 08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/29/2022 |
4
| TOMBESI PAOLO (EVP & CFO) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 1,183 shares
@ $74.94, valued at
$88.7k
|
|
| 07/19/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 07/19/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 07/01/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 07/01/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 06/24/2022 |
8-K
| Quarterly results |
| 06/21/2022 |
8-K
| Quarterly results |
| 06/17/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
|